Wedbush lowered the firm’s price target on DocuSign (DOCU) to $85 from $100 and keeps a Neutral rating on the shares. The firm notes that the company reported its Q1 results featuring beats across the top and bottom lines, which was largely overshadowed by the billings miss and lower FY26 billings guidance as the company looks to further improve its IAM strategy while innovating rapidly at scale.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU:
- DocuSign price target lowered to $77 from $81 at JPMorgan
- DocuSign price target lowered to $80 from $85 at UBS
- DocuSign price target lowered to $85 from $93 at Baird
- DocuSign price target lowered to $86 from $92 at Morgan Stanley
- DocuSign’s Transitional Challenges and Strategic Investments Lead to Hold Rating